DAIC

DECEMBER 19, 2023

OSA disproportionately affects the 92 million Americans living with cardiovascular disease (CVD), often goes undiagnosed (1) , and doubles the risk for heart failure and other serious cardiovascular conditions. Western Regional Director of Cardiac Electrophysiology, Northwell Health , NY.

Heart Failure 52

Heart Failure Innovation Heart Disease Quality of Life 52

DAIC

DECEMBER 26, 2023

For more information: www.jacc.org If you enjoy this content, please share it with a colleague

Innovation 52

Innovation Research Cardiovascular Imaging Electrophysiology 52

DAIC

JUNE 25, 2024

HHNM will use the Allia IGS Pulse system in its cardiac electrophysiology (EP) lab to plan, guide and monitor the outcomes of electrophysiological procedures, such as cardiac ablations, cardiac catherizations, transcatheter aortic valve replacements, balloon and coronary angioplasties and more. It’s an honor to have the U.S.’s

Electrophysiology 105

Electrophysiology Hospital Aortic valve Heart Disease 105

DAIC

FEBRUARY 2, 2024

milla1cf Fri, 02/02/2024 - 17:18 February 2, 2024 — GE HealthCare (Nasdaq: GEHC) announces the latest innovation in electrophysiology (EP), the Prucka 3 with CardioLab EP Recording system, to help clinicians in the diagnosis and treatment of cardiac arrhythmias. million people in the United States by 2050 and 17.9 million in Europe by 2060.

Electrophysiology 101

Electrophysiology Innovation AFIB Atrial Fibrillation 101

DAIC

MAY 31, 2024

Joaquin Duato , Chairman and Chief Executive Officer of Johnson & Johnson, said, “Through Innovative Medicine and MedTech, Johnson & Johnson is transforming the trajectory of cardiovascular disease, one of the leading causes of death globally.

Peripheral Arterial Disease 104

Peripheral Arterial Disease Innovation Coronary Artery Disease Cardiovascular Interventions 104

DAIC

FEBRUARY 14, 2025

The TAILORED-AF trial, highlights AIs ability to help physicians treat cardiovascular disease and improve patient outcomes. Voltas AI solution finally offers a solution for this large and underserved patient population, said Thophile Mohr-Durdez, CEO and co-founder of Volta Medical. adult population.

Atrial Fibrillation 52

Atrial Fibrillation Ablation Technology Pulmonary 52

DAIC

APRIL 5, 2024

These acquisitions complement and build on Johnson & Johnson’s established global leadership position in electrophysiology through the Biosense Webster portfolio. Following the close of the transaction, Johnson & Johnson MedTech will be a category leader in four high-growth cardiovascular segments.

Cardiovascular Interventions 105

Cardiovascular Interventions Technology Innovation Angina 105

DAIC

JUNE 19, 2024

While the spotlight in 2023 shone on developments around Generative Artificial Intelligence (AI), away from the limelight a quiet revolution in AI was taking place, which promises to transform the way we diagnose, manage, and treat cardiovascular diseases, the world’s leading cause of death.

AFIB 105

AFIB Reimbursement Research Atrial Fibrillation 105

DAIC

JANUARY 19, 2024

“I am grateful to my ACC colleagues for recognizing our work with this prestigious award,” said Chugh, associate director of the Smidt Heart Institute and the Pauline and Harold Price Chair in Cardiac Electrophysiology Research at Cedars-Sinai. The credit goes to my mentees and colleagues over the years.

Cardiac Arrest 105

Cardiac Arrest Heart Rhythm Electrophysiology Sudden Cardiac Death 105

DAIC

DECEMBER 14, 2023

It's a major step towards fulfilling our vision of providing disruptive electrophysiology solutions for patients," said Rebecca Seidel, SVP and President of the Cardiac Ablation Solutions business, which is part of the Cardiovascular Portfolio. For more information: www.medtronic.com References: Verma A, et al. Circulation.

Atrial Fibrillation 105

Atrial Fibrillation Ablation Technology Heart Failure 105

Open Heart

JUNE 1, 2022

Aim Inflammatory cytokines in patients with rheumatoid arthritis (RA) directly affect cardiac electrophysiology by inhibiting cardiac potassium currents, leading to delay of cardiac repolarisation and QT-prolongation. Stratified analyses were performed according to sex and presence of cardiovascular diseases.

Cardiac Arrest 52

Cardiac Arrest Hospital Cardiovascular Disease Electrophysiology 52

Circulation: Arrhythmia and Electrophysiology

NOVEMBER 29, 2023

Circulation: Arrhythmia and Electrophysiology, Ahead of Print. BACKGROUND:Sustained forms of atrial fibrillation (AF) are associated with lower treatment success rates and poorer prognosis compared with paroxysmal AF. Yet, little is known about risk factors that predispose to persistent AF on initial presentation.

Risk Factors 40

Risk Factors Atrial Fibrillation Education Cardiovascular Disease 40

HeartRhythm

JUNE 4, 2024

Diabetes mellitus (DM) confers an increased risk of sudden cardiac death (SCD) independent of its associated cardiovascular comorbidities. Diabetes mellitus induces adverse structural, electrophysiological, and autonomic cardiac remodeling which can increase one’s risk of ventricular arrhythmias and SCD.

Sudden Cardiac Death 40

Sudden Cardiac Death Arrhythmia Diabetes Electrophysiology 40

Cardiology Update

APRIL 9, 2024

Investigators assessed if empagliflozin could lower the risk of hospitalization for heart failure (HF) or death from cardiovascular disease (CVD). EMPACT-MI 1 ( NCT04509674 ) studied the effects of empagliflozin in patients who have experienced myocardial infarction (MI).

Angina 52

Angina Myocardial Infarction Aortic valve Coronary Artery Disease 52

American College of Cardiology

FEBRUARY 1, 2025

And sex-specific cardiovascular education of trainees and the entire care team is imperative," says Laxmi Mehta, MD, FACC, director of preventive cardiology and women's cardiovascular health at The Ohio State University Wexner Medical Center in Columbus. We need to learn the tools and how to deal with that anxiety well." "In

Cardiovascular Disease 42

Cardiovascular Disease Education Coronary Artery Disease Risk Factors 42

Cardiometabolic Health Congress

DECEMBER 7, 2023

Published on November 30, 2023, in the Journal of the American College of Cardiology, these new guidelines are based on a comprehensive literature review from May 2022 to November 2022, and provide important recommendations to clinicians caring for patients with or at risk of developing cardiovascular disease (CVD).

Atrial Fibrillation 111

Atrial Fibrillation Risk Factors Ablation Stroke 111

Dr. Smith's ECG Blog

APRIL 8, 2015

History of Cardiovascular disease (all studies): Especially any history of heart failure or structural cardiac disease, including valvular 4. Electrophysiologic studies were performed in selected patients only as clinically appropriate. Age greater than 65 (Sarasin and STePS) 3. g/dL —Hypotension (obviously!)

Arrhythmia 52

Arrhythmia Outcomes Chest Pain Risk Factors 52

DAIC

MARCH 17, 2025

editions are designed to improve the user experience, elevating workflow in the cardiac catheterization (cath) lab and supporting even the most complex electrophysiology (EP) procedures. Cardiovascular disease (CVD) has nearly doubled over the past three decades, affecting more than 500 million people worldwide. .* AltiX AI.i

Document 59

Document Coronary Artery Disease Innovation Cardiovascular Disease 59